Epizyme, Genentech, Roche deal

Roche’s Genentech unit and Epizyme partnered to conduct a Phase Ib trial to evaluate

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE